Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Rhinomed Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

28 Mar 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - RHINOMED LTD (RNO-AU)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

01 Apr 2015 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Rhinomed Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

06 Mar 2015 Wright Reports 53 $75.00

Rhinomed Limited

Rhinomed Limited is a leading medical technology company developing innovative nasal, respiratory and nasal drug delivery te...

11 Nov 2014 Acquisdata 11 $15.00

Rhinomed in 2nd daily rise, nears six-month high

Rhinomed Limited (ASX:RNO), Australia's 35th largest pharmaceuticals, biotechnology & life sciences company by market cap, ex...

07 Jul 2014 BuySellSignals Research 17 $5.00

Rhinomed up 7.4% in 2 days

Rhinomed Limited (ASX:RNO), Australia's 39th largest pharmaceuticals, biotechnology & life sciences company by market capital...

14 Apr 2014 BuySellSignals Research 17 $5.00

Company Snapshot - Rhinomed Ltd

Five Directors at Rhinomed Ltd bought/maiden bought 1,608,548 shares at between 0.045AUD and 0.048AUD. The significance ratin...

13 Feb 2014 Directors Deals Ltd. 1 $12.00

Consegna Group Limited (CGP) - Financial Analysis Review

Consegna Group Limited (CGP) - Financial Analysis Review Summary Consegna Group Limited (Consegna Group), formerly Heli...

10 Feb 2014 GlobalData 23 $125.00

Rhinomed keeps rising: up 11.5% in 3 days

Rhinomed Limited (ASX:RNO), Australia's 40th largest pharmaceuticals, biotechnology & life sciences company by market capital...

24 Jan 2014 BuySellSignals Research 17 $5.00

Rhinomed keeps rising: up 9.6% in 2 days

Rhinomed Limited (ASX:RNO), Australia's 39th largest pharmaceuticals, biotechnology & life sciences company by market capital...

23 Jan 2014 BuySellSignals Research 17 $5.00